A5034821603- Congenital Heart Disease Studies
- Cardiac Valve Diseases and Treatments
- Mechanical Circulatory Support Devices
- Vascular anomalies and interventions
- Aortic Disease and Treatment Approaches
- Coronary Artery Anomalies
- Pulmonary Hypertension Research and Treatments
- Cardiac Structural Anomalies and Repair
- Cardiovascular Conditions and Treatments
- Cardiovascular and Diving-Related Complications
- Cardiac Arrhythmias and Treatments
- Central Venous Catheters and Hemodialysis
- Renal and Vascular Pathologies
- Cardiovascular Issues in Pregnancy
- Congenital Diaphragmatic Hernia Studies
- Ultrasound in Clinical Applications
- Vascular Anomalies and Treatments
- Tracheal and airway disorders
- Infective Endocarditis Diagnosis and Management
- Vascular Procedures and Complications
- Cardiac Imaging and Diagnostics
- Cardiac Arrest and Resuscitation
- Venous Thromboembolism Diagnosis and Management
- Radiation Dose and Imaging
- Cardiac pacing and defibrillation studies
Rady Children's Hospital-San Diego
2021-2025
University of California, San Diego
2022-2025
Cedars-Sinai Medical Center
2023
Sinai Hospital
2023
Texas Children's Hospital
2013-2022
Baylor College of Medicine
2013-2022
Baylor University
2021
Emory University
2012-2017
Children's Healthcare of Atlanta
2016-2017
Children's Hospital of Philadelphia
2011-2017
Abstract Objectives Characterize the safety and effectiveness of Amplatzer Piccolo Occluder for patent ductus arteriosus (PDA) closure. Background The presence a hemodynamically significant PDA has been associated with an increased risk morbidity mortality in children born premature. Methods This was single arm, prospective, multicenter, non‐randomized study to evaluate treat patients ≥700 g. From June 2017 February 2019, 200 were enrolled at nine centers, 100 weighing ≤2 kg. Primary...
Objectives To describe the early multicenter, clinical experience with Medtronic Micro Vascular Plug™ (MVP) for occlusion of patent ductus arteriosus (PDA) in premature infants. Background The MVP is a large diameter plug that can be delivered through microcatheter abnormal blood vessels. Methods A Retrospective review PDA embolization procedures performed two centers using was performed. Results Fifteen infants underwent attempted MVP. gestational age and birth weight were 25.6 ± 2.5 weeks...
Background Patients with single-ventricle physiology who undergo the Fontan procedure are at risk for thrombotic events associated significant morbidity and mortality. The UNIVERSE Study evaluated efficacy safety of a novel liquid rivaroxaban formulation, using body weight-adjusted dosing regimen, versus acetylsalicylic acid (ASA) in children post-Fontan. Methods Results was randomized, multicenter, 2-part, open-label study rivaroxaban, had undergone procedure, to evaluate its safety,...
The Harmony transcatheter pulmonary valve (TPV) is the first U.S. Food and Drug Administration–approved device for severe regurgitation (PR) in native or surgically repaired right ventricular outflow tract (RVOT). One-year safety effectiveness of TPV were evaluated patients from Native Outflow Tract Early Feasibility Study, Pivotal Continued Access representing largest cohort to date recipients. Eligible had PR by echocardiography fraction ≥ 30% cardiac magnetic resonance imaging clinical...
Surgical cutdown for access to the common carotid artery provides a more direct route certain pediatric cardiac interventions and avoids femoral injury in small infants. The safety of percutaneous (PCA) children is unknown.Retrospective review PCA at Texas Children's Hospital Healthcare Atlanta. From July 2006 November 2014, 42 patients underwent 47 attempts catheterization via PCA. Median (range) age was 20 days (0 days-2.9 years) weight 3.2 kg (1.1-12.2). Two had failed with no sequelae....
This study describes 3-year follow-up of 200 infants weighing ≥ 700 grams who underwent transcatheter patent ductus arteriosus (PDA) closure with the Amplatzer Piccolo™ Occluder.Between June 2017 and February 2019, children were enrolled in this U.S. (NCT03055858). PDA closure, survival, device- or procedure-related events evaluated. A total 156 available 182 patients (86%) completed study.The implant success rate was 95.5% (191/200). At 3 years, observed 100% (33/33) patients. Survival >95%...
Abstract Objectives: Determine the long‐term outcomes of branch pulmonary artery (PA) stents. Background: PA stents in congenital heart disease effectively relieve stenoses short‐term. Published data are limited. Methods : Patients enrolled an FDA IDE protocol from 1989–92 were included. Clinical follow‐up and catheterization evaluated. included if >5 year was available or mortality occurred following initial procedure. Results There five deaths: four due to progression their underlying...
Objectives The objective was to review the use of Impella devices (Abiomed Inc, Danvers, MA) for temporary circulatory support in pediatric and adolescent patients (age ≤ 21 yrs). Background Options minimally invasive children are limited, published data confined case reports small series. Methods This a retrospective, multicenter implants from 2009‐15, using standardized collection INTERMACS definitions. Results A total 39 were performed 38 16 centers. Median age weight yrs (4–21 yrs) 62 kg...
Abstract Objective Comparison of outcomes using bare metal (BMS) and drug‐eluting (DES) stents in pulmonary vein stenosis (PVS). Background PVS is a serious condition with frequent restenosis after surgical percutaneous interventions. After experiencing encouraging results DES, we sought to compare BMS DES native post‐surgical PVS. Methods Results A retrospective review all patients who underwent stent implantation between 08/93 11/17 for at Texas Children's Hospital was performed. were used...
Background— Outcomes after right ventricle (RV) decompression in infants with pulmonary atresia intact ventricular septum vary widely. Descriptions of outcomes are limited to small single-center studies. Methods and Results— Neonates undergoing RV for were included from 4 pediatric centers. Primary end point was reintervention post-RV decompression; secondary points circulation type at latest follow-up. Ninety-nine patients (71 28 virtual atresia) underwent median 3 (25th–75th, 2–5) days...
Background— We sought to determine the safety and efficacy of Cutting Balloon therapy (CB) compared with conventional high-pressure balloon (HPB) for treatment pulmonary artery stenosis. Methods Results— This prospective, randomized, multicenter, investigational device exemption trial CB HPB. Patient eligibility was determined at precatheterization assessment; vessel catheterization. In all vessels, low-pressure dilation 8 atm performed, if it not successful, randomized or The primary...
We conducted a survey to determine which management options pediatric cardiologists and cardiac surgeons in North America discuss recommend when counseling parents after the diagnosis of hypoplastic left heart syndrome (HLHS).Pediatric across were asked complete an anonymous, Internet-based about their attitudes practices regarding HLHS.We contacted 1621 surgeons, whom 749 (46%) completed survey. When newborns with HLHS, 99.7% respondents discussed staged palliative surgery, 67%...
To describe the use of inhaled or endotracheally instilled tranexamic acid in critically ill pediatric patients for treatment pulmonary hemorrhage, which can be severe, life-threatening, and include potentially high-risk management procedures.Retrospective observational study from 2011-2018 with followed until hospital discharge.Free-standing children's an annual ICU volume more than 3,500 yearly admissions.Pediatric patients, ages 0 to 18 years, admitted who received at least one dose were...